|
業務類別
|
Biotechnology |
|
業務概覽
|
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broadtherapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries. |
| 公司地址
| One Pennsylvania Plaza, Suite 1025, New York, NY, USA, 10119 |
| 電話號碼
| +1 212 605-0300 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.lbpharma.us |
| 員工數量
| 16 |
| Dr. Richard Silva, PhD |
Senior Vice President, Technical Operations |
-- |
22/08/2025 |
| Ms. Heather Turner |
Chief Executive Officer and Director |
-- |
22/08/2025 |
| Mr. Marc Panoff |
Senior Vice President, Finance |
-- |
22/08/2025 |
| Mr. Gad Soffer |
Chief Business Officer |
-- |
22/08/2025 |
| Dr. Anna Eramo, M.D. |
Chief Medical Officer |
-- |
22/08/2025 |
|
|
| Dr. Rajul Jain, M.D. |
Independent Director |
22/08/2025 |
| Dr. Robert R. Ruffolo, D.Sc.,Jr,PhD |
Independent Director |
22/08/2025 |
| Mr. Zachary Prensky, M.D. |
Director |
22/08/2025 |
| Mr. Scott Garland |
Chairman of the Board |
22/08/2025 |
| Mr. Ran Nussbaum, M.D. |
Independent Director |
22/08/2025 |
| Dr. Chen Yu, M.D. |
Independent Director |
22/08/2025 |
| Ms. Heather Turner |
Chief Executive Officer and Director |
22/08/2025 |
| Ms. Rebecca Luse, M.D. |
Independent Director |
22/08/2025 |
|
|
|
|
